p53 negatively regulates the osteogenic differentiation of vascular smooth muscle cells in mice with chronic kidney disease KL LI, J ChEN, zh LI, J zhAN, L zhAO, yN hE Aim: To investigate the osteogenic differentiation of vascular smooth muscle cells (VSMCs) in mice with chronic kidney disease (CKD) and to evaluate the effects of p53 on the osteo-genic differentiation of the VSMCs. Methods: Experimental models of CKD-associated vascular calcification generated by five-sixth (5/6) nephrectomy (Nx) and a high-phosphate (HP) diet were used in p53+/+ and p53–/ – mice. Following 5/6 Nx, aortic calcification, mark-ers of osteogenic differentiation, VSMCs and p53 protein in aortic tissues were studied. Results: Aortic calcification was observed after eight weeks following 5/6 Nx in mice of both genotypes, and expression of the markers of osteogenic differentiation in the VSMCs was increased. These changes were continuously observed up to 12 weeks after 5/6 Nx, and particularly after 5/6 Nx + HP. Compared with p53+/+ mice, aortic calcification in p53–/– mice was more severe (p < 0.001). Expression of the mark-ers of osteogenic differentiation was noticeably increased (p < 0.001), while expression of the marker of VSMCs had decreased (p < 0.001). Statistical analysis demonstrated that the markers of osteogenic differentiation were negatively correlated with p53, and the marker of VSMCs was positively correlated with p53 (p < 0.001). Conclusion: p53 has the potential to negatively regulate the osteogenic differentiation of VSMCs in CKD mice.